Identification of membrane-type matrix metalloproteinase-1 as a target of the beta-catenin/Tcf4 complex in human colorectal cancers. (Q53387673)

13 May 2018

title

Identification of membrane-type matrix metalloproteinase-1 as a target of the beta-catenin/Tcf4 complex in human colorectal cancers. (English)

1 reference

13 May 2018

author name string

Meiko Takahashi

1

1 reference

13 May 2018

Tatsuhiko Tsunoda

2

1 reference

13 May 2018

Motoharu Seiki

3

1 reference

13 May 2018

Yusuke Nakamura

4

1 reference

13 May 2018

Yoichi Furukawa

5

1 reference

13 May 2018

language of work or name

English

0 references

publication date

1 August 2002

1 reference

13 May 2018

published in

Oncogene

1 reference

13 May 2018

volume

21

1 reference

13 May 2018

issue

38

1 reference

13 May 2018

page(s)

5861-5867

1 reference

13 May 2018

beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205755

Matrix metalloproteinase inhibition: a review of anti-tumour activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205755

Membrane type 1 matrix metalloproteinase (MT1-MMP) cleaves the recombinant aggrecan substrate rAgg1mut at the 'aggrecanase' and the MMP sites. Characterization of MT1-MMP catabolic activities on the interglobular domain of aggrecan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205755

Induction of matrix metalloproteinase activation cascades based on membrane-type 1 matrix metalloproteinase: associated activation of gelatinase A, gelatinase B and collagenase 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205755

The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205755

Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205755

Membrane-type 1 MMP (MMP-14) cleaves at three sites in the aggrecan interglobular domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205755

PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205755

Identification of c-MYC as a target of the APC pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205755

Regulation of cell invasion and morphogenesis in a three-dimensional type I collagen matrix by membrane-type matrix metalloproteinases 1, 2, and 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205755

Significance of membrane type 1 matrix metalloproteinase expression in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205755

Membrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205755

In vitro anti-tumour activity of alpha-galactosylceramide-stimulated human invariant Valpha24+NKT cells against melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205755

TIMP-2 promotes activation of progelatinase A by membrane-type 1 matrix metalloproteinase immobilized on agarose beads

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205755

Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase a (MMP-2) are able to generate active enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205755

Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205755

Role of cell surface metalloprotease MT1-MMP in epithelial cell migration over laminin-5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205755

Structural analysis and promoter characterization of the human membrane-type matrix metalloproteinase-1 (MT1-MMP) gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205755

Target genes of beta-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205755

Claudin promotes activation of pro-matrix metalloproteinase-2 mediated by membrane-type matrix metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205755

Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205755

Regulation of intracellular beta-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205755

Matrix metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205755

Transmembrane/cytoplasmic domain-mediated membrane type 1-matrix metalloprotease docking to invadopodia is required for cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205755

Axin, an inhibitor of the Wnt signalling pathway, interacts with beta-catenin, GSK-3beta and APC and reduces the beta-catenin level

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205755

Matrix metalloproteinases: biologic activity and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205755

Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205755

Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205755

Binding of GSK3beta to the APC-beta-catenin complex and regulation of complex assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205755

Phase I clinical trial of oral COL-3, a matrix metalloproteinase inhibitor, in patients with refractory metastatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205755

A matrix metalloproteinase expressed on the surface of invasive tumour cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205755

AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205755

Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205755

Expression of CD44 in Apc and Tcf mutant mice implies regulation by the WNT pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205755

Phosphorylation of axin, a Wnt signal negative regulator, by glycogen synthase kinase-3beta regulates its stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205755

MT1-MMP and MMP-2 mRNA expression in human ovarian tumors: possible implications for the role of desmoplastic fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205755

7 January 2021

Membrane-type matrix metalloproteinase-1(MT1-MMP) gene is overexpressed in highly invasive hepatocellular carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205755

7 January 2021

Anti-metastatic efficacy and safety of MMI-166, a selective matrix metalloproteinase inhibitor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205755

7 January 2021

Involvement of claudin-1 in the beta-catenin/Tcf signaling pathway and its frequent upregulation in human colorectal cancers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205755

7 January 2021

Expression and localization of matrix-degrading metalloproteinases during colorectal tumorigenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205755

7 January 2021

Membrane-type matrix metalloproteinases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205755

7 January 2021

Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human oral squamous cell carcinomas: implications for lymph node metastasis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205755

7 January 2021

Expression of MMP-7(PUMP-1) mRNA in human colorectal cancers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205755

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1205755

1 reference

13 May 2018

1 reference

13 May 2018